Literature DB >> 25963713

[Epithelial neuroendocrine tumors of the upper respiratory tract: New entities, new perspectives].

A Brobeil1, T Dreyer, R Schäffer, A Bräuninger, S Gattenlöhner.   

Abstract

Epithelial neuroendocrine tumors of the upper respiratory tract are rare and are classified as typical and atypical carcinoid versus small cell neuroendocrine carcinoma. Furthermore, a giant cell variant of neuroendocrine carcinoma is suggested corresponding to the bronchopulmonary system as well as a recently described subtype of oropharyngeal small cell neuroendocrine carcinoma associated with human papillomavirus. Many arguments relying on clinical as well as on molecular findings indicate that the distinction between carcinoid and poorly differentiated neuroendocrine carcinoma does not only reflect different degrees of differentiation of otherwise related tumors but indicates the existence of substantially different types of neoplasms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25963713     DOI: 10.1007/s00292-015-0031-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  50 in total

1.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

Review 2.  Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management.

Authors:  Alfio Ferlito; Kenneth O Devaney; Alessandra Rinaldo
Journal:  Oral Oncol       Date:  2006-07-11       Impact factor: 5.337

3.  Large cell neuroendocrine carcinoma of the larynx: definition of an entity.

Authors:  James S Lewis; David C Spence; Simon Chiosea; E Leon Barnes; Margaret Brandwein-Gensler; Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2010-06-30

4.  Sinonasal undifferentiated carcinoma: a distinctive and highly aggressive neoplasm.

Authors:  P A Levine; H F Frierson; F M Stewart; S E Mills; R E Fechner; R W Cantrell
Journal:  Laryngoscope       Date:  1987-08       Impact factor: 3.325

5.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.

Authors:  W D Travis; W Rush; D B Flieder; R Falk; M V Fleming; A A Gal; M N Koss
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

6.  Management of nonsinonasal neuroendocrine carcinomas of the head and neck.

Authors:  Jerry L Barker; Bonnie S Glisson; Adam S Garden; Adel K El-Naggar; William H Morrison; K Kian Ang; K S Clifford Chao; Gary Clayman; David I Rosenthal
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

7.  Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.

Authors:  Manal M Hassan; Alexandria Phan; Donghui Li; Cecile G Dagohoy; Colleen Leary; James C Yao
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

8.  Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status.

Authors:  Shanaz Begum; William H Westra
Journal:  Am J Surg Pathol       Date:  2008-07       Impact factor: 6.394

9.  Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy.

Authors:  R M Levenson; D C Ihde; M J Matthews; M H Cohen; A F Gazdar; P A Bunn; J D Minna
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

10.  High-dose chemotherapy and autologous marrow transplantation for esthesioneuroblastoma and sinonasal undifferentiated carcinoma.

Authors:  F M Stewart; H M Lazarus; P A Levine; K A Stewart; I A Tabbara; C A Spaulding
Journal:  Am J Clin Oncol       Date:  1989-06       Impact factor: 2.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.